Atea Pharma stock jumps as earnings rise, potential COVID-19 therapy advances

Shares of Atea Pharmaceuticals Inc. were trading over 18% higher in the after-hours market Monday, following the company's release of fourth-quarter financial results and news of upcoming drug trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.